This topic contains a solution. Click here to go to the answer

Author Question: Anxiolytics (minor tranquilizers) and antipsychotics (major tranquilizers) are likely to differ a ... (Read 59 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582
Anxiolytics (minor tranquilizers) and antipsychotics (major tranquilizers) are likely to differ a great deal in terms of their
 
  a. efficacy in reducing the symptoms of schizophrenia
  b. ability to induce seizure activity
  c. ability to decrease muscle tone and tension
  d. all of these

Question 2

Drugs used to reduce parkinsonism symptoms induced by antipsychotic drugs generally possess
 
  a. anticholinergic properties
  b. antiadrenergic properties
  c. antiserotonergic properties
  d. antidopaminergic properties



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

marict

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

d

Answer to Question 2

a




Shelles

  • Member
  • Posts: 582
Reply 2 on: Jun 22, 2018
:D TYSM


duy1981999

  • Member
  • Posts: 341
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library